| Dr Carlos Alberto Barbosa, MD | |
|
Urb. Martorell D2, Calle L. Munoz Rivera, Dorado, PR 00646-2707 | |
| (787) 565-9581 | |
| Not Available |
| Full Name | Dr Carlos Alberto Barbosa |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant - Medical |
| Location | Urb. Martorell D2, Dorado, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568233286 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 1960-PA (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Carlos Alberto Barbosa, MD Po Box 61, Dorado, PR 00646-0061 Ph: (787) 565-9581 | Dr Carlos Alberto Barbosa, MD Urb. Martorell D2, Calle L. Munoz Rivera, Dorado, PR 00646-2707 Ph: (787) 565-9581 |
News Archive
Brookdale Senior Living Inc. today reported financial and operating results for the third quarter of 2013.
AFREZZA (insulin human [rDNA origin]) Inhalation Powder, a well-tolerated, investigational ultra rapid acting mealtime insulin, as part of a diabetes treatment regimen, provides long-term glucose control comparable to usual insulin therapy but with a significantly reduced incidence of hypoglycemia and less weight gain in patients with Type 2 diabetes, according to a two-year study presented today at the American Diabetes Association's 70th Scientific Sessions.
A new study in Health Services Research finds nearly three-quarters of physicians using electronic health records (EHRs) in 2011 said there were clinical benefits when patients' medical histories were kept in digital files. The study focused on doctors' perceptions of clinical benefits to patient care when EHRs were in place.
Researchers leading the largest genomic tumor profiling effort of its kind say such studies are technically feasible in a broad population of adult and pediatric patients with many different types of cancer, and that some patients can benefit by receiving precision drugs targeted to their tumors' mutations or being enrolled in clinical trials.
New analyses from the Women's Health Initiative (WHI) confirm that combination hormone therapy increases the risk of heart disease in healthy postmenopausal women. Researchers report a trend toward an increased risk of heart disease during the first two years of hormone therapy among women who began therapy within 10 years of menopause, and a more marked elevation of risk among women who began hormone therapy more than 10 years after menopause. Analyses indicate that overall a woman's risk of heart disease more than doubles within the first two years of taking combination HT.
› Verified 1 days ago
Jesus Ramiro Davila-rosa, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Calle Kennedy Parcela 35-e Bo. Mameyal, Dorado, PR 00646 Phone: 939-599-1491 | |
Dr. Juan Jose Sosa Sr., MD MPH Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Paseo Del Plata Shopping Village, 604 Ave. Jose Efrom #50, Dorado, PR 00646 Phone: 787-965-2040 | |
Evelio A Curbelo, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: Paseo Los Corales I, 564 Calle Golfo De Mexico, Dorado, PR 00646 Phone: 873-789-8937 |